Cargando…
A Difficult Challenge for the Clinical Laboratory: Accessing and Interpreting Manufacturer Cross-Reactivity Data for Immunoassays Used in Urine Drug Testing
Urine drug testing by immunoassay is widely used to detect nonmedical drug use and to monitor patients prescribed controlled substances. A key attribute of urine drug testing immunoassays is cross-reactivity, namely the response of various compounds compared to the target of the assay. In this repor...
Autores principales: | Reschly-Krasowski, Justine M., Krasowski, Matthew D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249658/ https://www.ncbi.nlm.nih.gov/pubmed/30480089 http://dx.doi.org/10.1177/2374289518811797 |
Ejemplares similares
-
Using cheminformatics to predict cross reactivity of “designer drugs” to their currently available immunoassays
por: Krasowski, Matthew D, et al.
Publicado: (2014) -
Data on hydroxychloroquine interference with urine laboratory testing
por: Kingery, Jennie M., et al.
Publicado: (2019) -
Educational Case: Regulatory Issues With Laboratory Testing
por: Krasowski, Matthew D.
Publicado: (2019) -
Educational Case: Hemolysis and Lipemia Interference With Laboratory Testing
por: Krasowski, Matthew D.
Publicado: (2019) -
Impact of Daylight Saving Time on the Clinical Laboratory
por: Ehlers, Alexandra, et al.
Publicado: (2018)